
Arkéa backs Sagesse Retraite Santé
New backer Arkéa Capital Partenaire, alongside existing investor Macif, an insurance group, have invested €75m in Sagesse Retraite Santé (SRS), a France-based holding vehicle of private investor Yves Journel dedicated to the healthcare sector.
Arkéa and Macif are minority investors, as the business remains 79% owned by its founder, Yves Journel.
French generalist GP Arkéa frequently invests in the healthcare sector. Examples of health-related companies it has previously invested in include ophthalmology consultation service Groupe Point Vision (2014), as well as biotechnology businesses Cisbio Bioassays (2016) and Hygeco (2017). Bioassays was divested in April this year.
Macif, founded in 1960 and based in Meaux, is an insurance group that offers services including health and pension insurance, and banking services. The corporate acted as an LP in BlackFin Tech Fund 1, which closed in Q3 2018.
Company
SRS, founded in 1990, holds majority and minority stakes in several businesses, including nursing groups DomusVi and Sedna, hospital group Almaviva Sante, home medical services provider Elivie, and hydrotherapy centre operator Arenadour, among others. SRS is based in Antibes.
The businesses backed by the company generate a combined €2.5bn turnover and employ 50,000 employees, according to a statement.
People
Sagesse Retraite Sante – Yves Journel (founder, owner); Pierre Chabaud (investment director).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater